Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 15;105(1):35–46. doi: 10.1111/ejh.13405

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Millennium Pharmaceuticals, Inc., Cambridge, MA, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited European Journal of Haematology Published by John Wiley & Sons Ltd

This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

CD19 and CD81 expression by prior treatment exposure and by c‐MYC expression. Median levels of (A) CD19 and (B) CD81 were significantly higher in tumors from 1LoT‐SCT vs 1LoT‐noSCT or 2/3LoT patients. No difference was observed between 1LoT‐noSCT and 2/3LoT patients. C, CD19, CD81, and CD79A were highly expressed in tumors in the lowest quartile for c‐MYC expression. Solid black horizontal lines show the medians, dotted orange lines show the overall medians, boxes show interquartile range, lines show range excluding outliers. LoT, line of therapy; SCT, stem cell transplantation [Colour figure can be viewed at wileyonlinelibrary.com]